[Skip to Content]
Regulatory Agencies

Irregularities and Misconduct in Clinical Trials: Increasing Access to FDA Inspection Reports

JAMA
Published Online: April 23, 2020 Audio Author Interview 18 min 35 sec
<title>Irregularities and Misconduct in Clinical Trials: Increasing Access to FDA Inspection Reports</title>
Backward 15 Play Pause Forward 15
1x
0:00 / 0:00
Download MP3

Interview with Aaron S. Kesselheim, MD, JD, MPH, author of Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials

Our websites may be periodically unavailable between 7:00pm CT February 4, 2023 and 1:00am CT February 5, 2023 for regularly scheduled maintenance.
Related Articles

  1. FDA Site Inspection Reports on RCT Irregularities and Misconduct—The Case For Transparency

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

See More About

Research, Methods, Statistics Regulatory Agencies
Close
Close

Name Your Search

Save Search
Privacy Policy|Terms of Use
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue